They found HSPG-mediated micropinocytosis is responsible for tau uptake in AD and DLB conditions, while the HSPG-mediated micropinocytosis and other pathways in other tauopathies are yet to be defined (Puangmalai et al., 2020). The gene discussed is MAPT; the disease is tauopathy.